Evelo Biosciences, Inc. (EVLO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Aug 7, 2026
Evelo Biosciences Market Cap
Evelo Biosciences has a market cap or net worth of $1.9 thousand as of August 10, 2026. Its market cap has decreased by -80.00% in one year.
Market Cap
1.90K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since May 9, 2018, Evelo Biosciences's market cap has decreased from 517.90M to 1.90K, a decrease of -100.00%. That is a compound annual growth rate of -78.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 1.90K | -80.00% |
| Dec 31, 2025 | 9.49K | - |
| Dec 30, 2024 | 9.49K | -99.19% |
| Dec 29, 2023 | 1.17M | -99.34% |
| Dec 30, 2022 | 176.48M | -45.62% |
| Dec 31, 2021 | 324.50M | -41.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syros Pharmaceuticals | 2.68K |
| Anthera Pharmaceuticals | 2.62K |
| TetraLogic Pharmaceuticals | 2.43K |
| OncoVista Innovative Therapies | 2.36K |
| Suvanza Pharma, LLC | 2.24K |
| Aditxt | 2.16K |
| Affimed | 1.64K |
| ZIM Corporation | 1.63K |